These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6457546

  • 1. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M, Koumaré B, Soussy CJ, Duval J.
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D, Pennucci C, Esposito S, Barba D.
    Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
    [Abstract] [Full Text] [Related]

  • 3. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D, Pennucci C, Esposito S, Galante D.
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
    Thabaut A, Durosoir JL.
    Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
    Esposito S, Galante D, Pennucci C, Barba D.
    Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO, Izard D, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B, Gille Y, Schmuck N, Assenat H, Adeleine P, Davoine P.
    Nephrologie; 1983 Dec; 4(6):259-62. PubMed ID: 6669186
    [Abstract] [Full Text] [Related]

  • 14. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
    Hoogkamp-Korstanje JA.
    Eur J Clin Microbiol; 1984 Aug; 3(4):333-8. PubMed ID: 6237901
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of the newer quinolones compared with the classic ones and tobramycin.
    Boquet Jiménez E, Dalet Escribá F, Caballé L.
    Infection; 1985 Aug; 13(4):193-6. PubMed ID: 2931382
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.